PRL-3 upregulation in colon cancer cells and primary fibroblasts induces telomere structural abnormalities, telomere deprotection, DNA damage response, chromosomal instability, and senescence, contributing to tumor progression [121]. This evidence concerns the gene PTP4A3 and colonic neoplasm.